Medtronic to announce financial results for its first quarter of fiscal year 2027
Rhea-AI Summary
Medtronic (NYSE: MDT) will report financial results for its first quarter of fiscal year 2027, which ended on July 31, 2026, on Tuesday, September 1, 2026. A news release will be issued at 5:45 a.m. CT, followed by a video webcast discussing the results at 6:45 a.m. CT, both accessible through Medtronic’s news and investor relations websites.
Positive
- None.
Negative
- None.
News Market Reaction – MDT
In the Jul 20 session, MDT gained 0.11%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 13 | earnings date | Neutral | +0.9% | Scheduled fiscal-year results and webcast logistics |
| Feb 11 | earnings date | Neutral | -0.3% | Scheduled quarterly results and investor webcast |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Tag-specific earnings-date announcements produced mixed reactions, with one positive and one negative 24-hour move.
Key Terms
forward-looking statements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
- A news release containing summary financial information will be issued at 5:45 a.m. Central Time (CT) and will be available at https://news.medtronic.com.
- A video webcast to discuss results will begin at 6:45 a.m. CT and can be accessed at https://investorrelations.medtronic.com.
- Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts:
Justin Paquette
Public Relations
+1-612-271-7935
Ingrid Goldberg
Investor Relations
+1-763-505-2696

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-first-quarter-of-fiscal-year-2027-302828870.html
SOURCE Medtronic plc